Citations (177)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Syed Shahariar Bappy, Sorna Sultana, Juthi Adhikari, Shafi Mahmud, Md. Arif Khan, K. M. Kaderi Kibria, Md. Masuder Rahman & Abu Zaffar Shibly. (2021) Extensive immunoinformatics study for the prediction of novel peptide-based epitope vaccine with docking confirmation against envelope protein of Chikungunya virus: a computational biology approach. Journal of Biomolecular Structure and Dynamics 39:4, pages 1139-1154.
Read now
Read now
Shree Madhu Bhat, Piya Paul Mudgal, Sudheesh n & Govindakarnavar Arunkumar. (2019) Spectrum of candidate molecules against Chikungunya virus - an insight into the antiviral screening platforms. Expert Review of Anti-infective Therapy 17:4, pages 243-264.
Read now
Read now
Hong-Lei Zhang, Hao-Long Dong, Ya-Nan Zhang, Lin-Lin Xu, Cheng-Lin Deng, Xiao-Feng Li, Xiao-Dan Li, Han-Qing Ye, Zhi-Ming Yuan, Cheng-Feng Qin & Bo Zhang. (2019) Visualization of chikungunya virus infection in vitro and in vivo. Emerging Microbes & Infections 8:1, pages 1574-1583.
Read now
Read now
Phuong N Pham, LaQueena T Williams, Uduak Obot, Luz A Padilla, Maung Aung, Tomi F Akinyemiju, April P Carson & Pauline E Jolly. (2017) Epidemiology of Chikungunya fever outbreak in Western Jamaica during July–December 2014. Research and Reports in Tropical Medicine 8, pages 7-16.
Read now
Read now
Peter Pushko, Igor S. Lukashevich, Scott C. Weaver & Irina Tretyakova. (2016) DNA-launched live-attenuated vaccines for biodefense applications. Expert Review of Vaccines 15:9, pages 1223-1234.
Read now
Read now
Michael Schwameis, Nina Buchtele, Patricia Pia Wadowski, Christian Schoergenhofer & Bernd Jilma. (2016) Chikungunya vaccines in development. Human Vaccines & Immunotherapeutics 12:3, pages 716-731.
Read now
Read now
Giovanni Rezza. (2015) Do we need a vaccine against chikungunya?. Pathogens and Global Health 109:4, pages 170-173.
Read now
Read now
Antonio Cassone. (2015) A vaccine against an explosively spreading virus. Pathogens and Global Health 109:2, pages 43-43.
Read now
Read now
Articles from other publishers (169)
Sivanandhan Subramaniyan, Ganesan Pathalam, Edwin Hillary Varghese, Tamilselvan C, Thamanna R. Y, Muthu Kanagavel Mariappan & Ignacimuthu Savarimuthu. (2023) Mushrooms (basidiomycetes) as source of mosquito control agents. Journal of Natural Pesticide Research 5, pages 100044.
Crossref
Crossref
Jimin Xu, Yu Xue, Andrew A. Bolinger, Jun Li, Mingxiang Zhou, Haiying Chen, Hongmin Li & Jia Zhou. (2023) Therapeutic potential of salicylamide derivatives for combating viral infections. Medicinal Research Reviews 43:4, pages 897-931.
Crossref
Crossref
João-Pedro Ferreira, Christa D. Court, Estefania Basurto-Cedeño & Lori Pennington-Gray. (2023) Using the 2016 Zika outbreak to estimate the potential tourism impacts of a Chikungunya event in Florida. Tourism Economics.
Crossref
Crossref
Christine A. Shaw, Allison August, Stephan Bart, Peta-Gay Jackson Booth, Conor Knightly, Trevor Brasel, Scott C. Weaver, HongHong Zhou & Lori Panther. (2023) A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults. Vaccine 41:26, pages 3898-3906.
Crossref
Crossref
Martina Schneider, Marivic Narciso-Abraham, Sandra Hadl, Robert McMahon, Sebastian Toepfer, Ulrike Fuchs, Romana Hochreiter, Annegret Bitzer, Karin Kosulin, Julian Larcher-Senn, Robert Mader, Katrin Dubischar, Oliver Zoihsl, Juan-Carlos Jaramillo, Susanne Eder-Lingelbach, Vera Buerger & Nina Wressnigg. (2023) Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial. The Lancet 401:10394, pages 2138-2147.
Crossref
Crossref
Emily N. Drwiega, Larry H. Danziger, Rodrigo M. Burgos & Sarah M. Michienzi. (2023) Commonly Reported Mosquito-Borne Viruses in the United States: A Primer for Pharmacists. Journal of Pharmacy Practice, pages 089719002311679.
Crossref
Crossref
Ana C. Puhl, Rafaela S. Fernandes, Andre S. Godoy, Laura H.V.G. Gil, Glaucius Oliva & Sean Ekins. (2023) The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus. Bioorganic & Medicinal Chemistry 83, pages 117239.
Crossref
Crossref
Gerardo Montalvo Zurbia-Flores, Arturo Reyes-Sandoval & Young Chan Kim. (2023) Chikungunya Virus: Priority Pathogen or Passing Trend?. Vaccines 11:3, pages 568.
Crossref
Crossref
Carina Z. Segato-Vendrameto, Camila Zanluca, Amanda Z. Zucoloto, Tiago H. Zaninelli, Mariana M. Bertozzi, Telma Saraiva-Santos, Camila R. Ferraz, Larissa Staurengo-Ferrari, Stephanie Badaro-Garcia, Marília F. Manchope, Amanda M. Dionisio, Felipe A. Pinho-Ribeiro, Sergio M. Borghi, Ana Luiza Pamplona Mosimann, Rubia Casagrande, Juliano Bordignon, Victor Fattori, Claudia N. Duarte dos Santos & Waldiceu A. Verri. (2023) Chikungunya Virus and Its Envelope Protein E2 Induce Hyperalgesia in Mice: Inhibition by Anti-E2 Monoclonal Antibodies and by Targeting TRPV1. Cells 12:4, pages 556.
Crossref
Crossref
Jacqueline Kyungah Lim, Valery Ridde, Selidji Todagbe Agnandji, Bertrand Lell, Seydou Yaro, Jae Seung Yang, Damien Hoinard, Scott C Weaver, Jessica Vanhomwegen, Henrik Salje & In-Kyu Yoon. (2023) Seroepidemiological Reconstruction of Long-term Chikungunya Virus Circulation in Burkina Faso and Gabon. The Journal of Infectious Diseases 227:2, pages 261-267.
Crossref
Crossref
W.J.P. Gotay, R.O. Rodrigues & J.N.U. Yaochite. (2023) Influence of host genetic polymorphisms involved in immune response and their role in the development of Chikungunya disease: a review. Brazilian Journal of Medical and Biological Research 56.
Crossref
Crossref
Elizabeth D. Barnett, Phyllis E. Kozarsky & Robert Steffen. 2023. Plotkin's Vaccines. Plotkin's Vaccines
1450
1468.e6
.
Taha Musa, Lovel Fornah, Akintunde Tosin Yinka, Upama Ghimire, Hassan Hussein Musa, Idriss Hussein Musa & Kayode Olayinka Afolabi. (2022) Mapping of research Productivity on Chikungunya indexed in Web of Sciences Core Collection. Pan Africa Science Journal 2:2, pages 215-245.
Crossref
Crossref
Laith Yakob. (2022) Predictable Chikungunya Infection Dynamics in Brazil. Viruses 14:9, pages 1889.
Crossref
Crossref
Chunyan Su, Kaiyun Ding, Jingwen Xu, Jianchao Wu, Jiansheng Liu, Jiayuan Shen, Hongning Zhou & Hongqi Liu. (2022) Preparation and application of chikungunya pseudovirus containing double reporter genes. Scientific Reports 12:1.
Crossref
Crossref
Khanzadi Nazneen Manzoor, Farakh Javed, Muhammad Ejaz, Mubashar Ali, Neelam Mujaddadi, Abid Ali Khan, Aamer Ali Khattak, Assad Zaib, Ibrar Ahmad, Waqar Khalid Saeed & Sobia Manzoor. (2021) The global emergence of Chikungunya infection: An integrated view. Reviews in Medical Virology 32:3.
Crossref
Crossref
Priti Sharma, Pawan Sharma, Sheeba Ahmad & Ajay Kumar. (2022) Chikungunya Virus Vaccine Development: Through Computational Proteome Exploration for Finding of HLA and cTAP Binding Novel Epitopes as Vaccine Candidates. International Journal of Peptide Research and Therapeutics 28:2.
Crossref
Crossref
Fleury Augustin Nsole Biteghe, Chalomie Nyangone Ekome Toung, Jean De La Croix Ndong, Neelakshi Mungra, Tahir B. Dar & Arnaud John Kombe Kombe. 2022. Chikungunya Virus - A Growing Global Public Health Threat. Chikungunya Virus - A Growing Global Public Health Threat.
Lingjun Zhu, Xiaodong Wang, Tania Akter Asa & Md. Ali Hossain. (2021) Identification of key genes, pathways, and associated comorbidities in chikungunya infection: insights from system biology analysis. Network Modeling Analysis in Health Informatics and Bioinformatics 10:1.
Crossref
Crossref
Muhammad H. Butt, Aqsa Safdar, Attiya Amir, Muhammad Zaman, Abrar Ahmad, Rana T. Saleem, Shahzadi Misbah, Yusra H. Khan & Tauqeer H. Mallhi. (2021) Arboviral diseases and COVID‐19 coincidence: Challenges for Pakistan's derelict healthcare system. Journal of Medical Virology 93:12, pages 6465-6467.
Crossref
Crossref
Nazish Badar, Aamer Ikram, Muhammad Salman, Muhammad Masroor Alam, Massab Umair, Yasir Arshad, Nighat Mushtaq, Hamza Ahmad Mirza, Abdul Ahad, Muhammad Talha Yasin & Javaria Qazi. (2021) Epidemiology of Chikungunya virus isolates 2016–2018 in Pakistan. Journal of Medical Virology 93:11, pages 6124-6131.
Crossref
Crossref
Juan García-Arriaza, Mariano Esteban & Daniel López. (2021) Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus. Biomedicines 9:9, pages 1122.
Crossref
Crossref
Soohyun Park, Hyunhyuk Tae & Nam-Joon Cho. (2021) Biophysical Measurement Strategies for Antiviral Drug Development: Recent Progress in Virus-Mimetic Platforms Down to the Single Particle Level. Accounts of Chemical Research 54:16, pages 3204-3214.
Crossref
Crossref
Rebecca S. Brown, Lisa Kim & Margaret Kielian. (2021) Specific Recognition of a Stem-Loop RNA Structure by the Alphavirus Capsid Protein. Viruses 13:8, pages 1517.
Crossref
Crossref
Jared Kirui, Yara Abidine, Annasara Lenman, Koushikul Islam, Yong-Dae Gwon, Lisa Lasswitz, Magnus Evander, Marta Bally & Gisa Gerold. (2021) The Phosphatidylserine Receptor TIM-1 Enhances Authentic Chikungunya Virus Cell Entry. Cells 10:7, pages 1828.
Crossref
Crossref
Larisa Ivanova, Kai Rausalu, Maksim Ošeka, Dzmitry G. Kananovich, Eva Žusinaite, Jaana Tammiku-Taul, Margus Lopp, Andres Merits & Mati Karelson. (2021) Novel Analogues of the Chikungunya Virus Protease Inhibitor: Molecular Design, Synthesis, and Biological Evaluation. ACS Omega 6:16, pages 10884-10896.
Crossref
Crossref
Getachew Ferede, Moges Tiruneh, Ebba Abate, Yitayih Wondimeneh, Endalamaw Gadisa, Rawleigh Howe, Abraham Aseffa & Belay Tessema. (2021) Evidence of chikungunya virus infection among febrile patients in northwest Ethiopia. International Journal of Infectious Diseases 104, pages 183-188.
Crossref
Crossref
Saravana Murali Krishnan, Jayashri Mahalingam, Shanthi Sabarimurugan, Thiruvengadam Muthu, Baskar Venkidasamy, Kaveri Krishnasamy, Ashutosh Sharma & Sathishkumar Ramalingam. (2021) Comparison of Cytokine Expression Profile in Chikungunya and Dengue Co-Infected and Mono-Infected Patients’ Samples. Pathogens 10:2, pages 166.
Crossref
Crossref
Salma El Adl & Alaa Badawi. 2021. Nuclear Receptors. Nuclear Receptors
483
502
.
Rafael Kroon Campos, Lorena Preciado-Llanes, Sasha R. Azar, Young Chan Kim, Olivia Brandon, César López-Camacho, Arturo Reyes-Sandoval & Shannan L. Rossi. (2020) Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model. Frontiers in Immunology 11.
Crossref
Crossref
Nina Wressnigg, Romana Hochreiter, Oliver Zoihsl, Andrea Fritzer, Nicole Bézay, Anton Klingler, Karen Lingnau, Martina Schneider, Urban Lundberg, Andreas Meinke, Julian Larcher-Senn, Irena Čorbic-Ramljak, Susanne Eder-Lingelbach, Katrin Dubischar & Wolfgang Bender. (2020) Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial. The Lancet Infectious Diseases 20:10, pages 1193-1203.
Crossref
Crossref
Chintana Chirathaworn, Jira Chansaenroj & Yong Poovorawan. (2020) Cytokines and Chemokines in Chikungunya Virus Infection: Protection or Induction of Pathology. Pathogens 9:6, pages 415.
Crossref
Crossref
Luca Galli & Fabrizio Bruschi. (2020) New strategies for the control of infectious and parasitic diseases in blood donors: the impact of pathogen inactivation methods. The EuroBiotech Journal 4:2, pages 53-66.
Crossref
Crossref
Rajesh Kumar, Tripti Shrivastava, Sweety Samal, Shubbir Ahmed & Hilal Ahmad Parray. (2020) Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection. Applied Microbiology and Biotechnology 104:8, pages 3209-3228.
Crossref
Crossref
Rupsa Basu, Lukai Zhai, Brenna Rosso & Ebenezer Tumban. (2020) Bacteriophage Qβ virus-like particles displaying Chikungunya virus B-cell epitopes elicit high-titer E2 protein antibodies but fail to neutralize a Thailand strain of Chikungunya virus. Vaccine 38:11, pages 2542-2550.
Crossref
Crossref
Nazish Badar, Muhammad Salman, Jamil Ansari, Uzma Aamir, Muhammad Masroor Alam, Yasir Arshad, Nighat Mushtaq, Aamer Ikram & Javaria Qazi. (2020) Emergence of Chikungunya Virus, Pakistan, 2016–2017. Emerging Infectious Diseases 26:2, pages 307-310.
Crossref
Crossref
Cristiam Victoriano Portilla Cabrera & John Josephraj Selvaraj. (2020) Geographic shifts in the bioclimatic suitability for Aedes aegypti under climate change scenarios in Colombia. Heliyon 6:1, pages e03101.
Crossref
Crossref
S. Zoa-Assoumou, A. Ndjoyi-Mbiguino, G. Mourembou & Moulay Mustapha Ennaji. 2020. Emerging and Reemerging Viral Pathogens. Emerging and Reemerging Viral Pathogens
241
252
.
Muhammad A. Saleem & Iryna Lobanova. 2020. Dengue Virus Disease. Dengue Virus Disease
57
83
.
Woo-Chang Chung, Kwang Yeon Hwang, Suk-Jo Kang, Jae-Ouk Kim & Moon Jung Song. (2019) Development of a neutralization assay based on the pseudotyped chikungunya virus of a Korean isolate. Journal of Microbiology 58:1, pages 46-53.
Crossref
Crossref
Samwel Saringe, Debora C. Kajeguka, Dickson D. Kagirwa, Maseke R. Mgabo & Basiliana Emidi. (2019) Healthcare workers knowledge and diagnostic practices: a need for dengue and chikungunya training in Moshi Municipality, Kilimanjaro Tanzania. BMC Research Notes 12:1.
Crossref
Crossref
Saravanan Gunaseelan, Kai Zhi Wong, Nyo Min, Jialei SunNur Khairiah Binte Mohd IsmailYee Joo TanRegina Ching Hua LeeJustin Jang Hann Chu. (2019) Prunin suppresses viral IRES activity and is a potential candidate for treating enterovirus A71 infection. Science Translational Medicine 11:516.
Crossref
Crossref
Maneesh Kumar, Roshan Kamal Topno, Manas Ranjan Dikhit, Bhawana, Ganesh Chandra Sahoo, Major Madhukar, Krishna Pandey & Pradeep Das. (2019)
Molecular docking studies of chloroquine and its derivatives against P23
pro‐zbd
domain of chikungunya virus: Implication in designing of novel therapeutic strategies
. Journal of Cellular Biochemistry 120:10, pages 18298-18308.
Crossref
Crossref
Lucía Carrau, Veronica V. Rezelj, María G. Noval, Laura I. Levi, Daniela Megrian, Herve Blanc, James Weger-Lucarelli, Gonzalo Moratorio, Kenneth A. Stapleford & Marco Vignuzzi. (2019)
Chikungunya Virus Vaccine Candidates with Decreased Mutational Robustness Are Attenuated
In Vivo
and Have Compromised Transmissibility
. Journal of Virology 93:18.
Crossref
Crossref
Tiffany A. Peterson, Andrew G. MacLean, Kasi E. Russell‐Lodrigue, Peter J. Didier, Scott C. Weaver & Chad J. Roy. (2019) Adverse event following live attenuated chikungunya vaccine in a cynomolgus macaque with pre‐existing chronic hydrocephalus. Journal of Medical Primatology 48:4, pages 257-259.
Crossref
Crossref
Leora R. Feldstein, Esther M. Ellis, Ali Rowhani-Rahbar, Morgan J. Hennessey, J. Erin Staples, M. Elizabeth Halloran & Marcia R. Weaver. (2019) Estimating the cost of illness and burden of disease associated with the 2014–2015 chikungunya outbreak in the U.S. Virgin Islands. PLOS Neglected Tropical Diseases 13:7, pages e0007563.
Crossref
Crossref
Siva Raghavendhar, Praveen Kumar Tripati, Pratima Ray & Ashok Kumar Patel. (2019) Evaluation of medicinal herbs for Anti-CHIKV activity.. Virology 533, pages 45-49.
Crossref
Crossref
Laura I. Levi & Marco Vignuzzi. (2019) Arthritogenic Alphaviruses: A Worldwide Emerging Threat?. Microorganisms 7:5, pages 133.
Crossref
Crossref
Young Chan Kim, César López-Camacho, Nallely Garcia-Larragoiti, Alan Cano-Mendez, Karina Guadalupe Hernandez-Flores, Carlos Alonso Domínguez-Alemán, Maria Antonieta Mar, Héctor Vivanco-Cid, Martha Eva Viveros-Sandoval & Arturo Reyes-Sandoval. (2019) Development of an E2 ELISA Methodology to Assess Chikungunya Seroprevalence in Patients from an Endemic Region of Mexico. Viruses 11:5, pages 407.
Crossref
Crossref
Priya Narang, Mehak Dangi, Deepak Sharma, Alka Khichi & Anil Kumar Chhillar. (2019) An Integrated Chikungunya Virus Database to Facilitate Therapeutic Analysis: ChkVDb. Current Bioinformatics 14:4, pages 323-332.
Crossref
Crossref
Giovanni Rezza & Scott C. Weaver. (2019) Chikungunya as a paradigm for emerging viral diseases: Evaluating disease impact and hurdles to vaccine development. PLOS Neglected Tropical Diseases 13:1, pages e0006919.
Crossref
Crossref
Cyril Caminade, K. Marie McIntyre & Anne E. Jones. (2018) Impact of recent and future climate change on vector‐borne diseases. Annals of the New York Academy of Sciences 1436:1, pages 157-173.
Crossref
Crossref
Guillaume Carissimo & Lisa F. P. Ng. 2019.
Francesco Vairo, Alessia Mammone, Simone Lanini, Emanuele Nicastri, Concetta Castilletti, Fabrizio Carletti, Vincenzo Puro, Domenico Di Lallo, Vincenzo Panella, Donatella Varrenti, Paola Scaramozzino, Antonino di Caro, Paola Scognamiglio, Maria Rosaria Capobianchi & Giuseppe Ippolito. (2018) Local transmission of chikungunya in Rome and the Lazio region, Italy. PLOS ONE 13:12, pages e0208896.
Crossref
Crossref
Emil C Reisinger, Roland Tschismarov, Eckhard Beubler, Ursula Wiedermann, Christa Firbas, Micha Loebermann, Andrea Pfeiffer, Matthias Muellner, Erich Tauber & Katrin Ramsauer. (2018) Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial. The Lancet 392:10165, pages 2718-2727.
Crossref
Crossref
Francesco Vairo, Carlo Di Pietrantonj, Chiara Pasqualini, Alessia Mammone, Simone Lanini, Emanuele Nicastri, Concetta Castilletti, Federica Ferraro, Virginia Di Bari, Vincenzo Puro, Paola Scognamiglio, Antonino Di Caro, Maria Capobianchi & Giuseppe Ippolito. (2018) The Surveillance of Chikungunya Virus in a Temperate Climate: Challenges and Possible Solutions from the Experience of Lazio Region, Italy. Viruses 10:9, pages 501.
Crossref
Crossref
Daniela Michlmayr, Theodore R Pak, Adeeb H Rahman, El‐Ad David Amir, Eun‐Young Kim, Seunghee Kim‐Schulze, Maria Suprun, Michael G Stewart, Guajira P Thomas, Angel Balmaseda, Li Wang, Jun Zhu, Mayte Suaréz‐Fariñas, Steven M Wolinsky, Andrew Kasarskis & Eva Harris. (2018) Comprehensive innate immune profiling of chikungunya virus infection in pediatric cases. Molecular Systems Biology 14:8.
Crossref
Crossref
Caleb E. Ward & Jennifer I. Chapman. (2018) Chikungunya in Children. Pediatric Emergency Care 34:7, pages 510-515.
Crossref
Crossref
John H. Huber, Marissa L. Childs, Jamie M. Caldwell & Erin A. Mordecai. (2018) Seasonal temperature variation influences climate suitability for dengue, chikungunya, and Zika transmission. PLOS Neglected Tropical Diseases 12:5, pages e0006451.
Crossref
Crossref
Ravi B. Sutaria, Jose K. Amaral & Robert T. Schoen. (2018) Emergence and treatment of chikungunya arthritis. Current Opinion in Rheumatology 30:3, pages 256-263.
Crossref
Crossref
Imelda Menchaca-Armenta, Moisés Ocampo-Torres, Arnulfo Hernández-Gómez & Karen Zamora-Cerritos. (2018) Risk perception and level of knowledge of diseases transmitted by Aedes aegypti. Revista do Instituto de Medicina Tropical de São Paulo 60:0.
Crossref
Crossref
Brendon Y. ChuaToshiki SekiyaDavid C. Jackson. (2018) Opinion: Making Inactivated and Subunit-Based Vaccines Work. Viral Immunology 31:2, pages 150-158.
Crossref
Crossref
Pratip Shil, Dilip R. Kothawale & Anakkathil B. Sudeep. (2018) Rainfall and Chikungunya incidences in India during 2010–2014. VirusDisease 29:1, pages 46-53.
Crossref
Crossref
Alaa Badawi, Seung Gwan Ryoo, Denitsa Vasileva & Sahar Yaghoubi. (2018) Prevalence of chronic comorbidities in chikungunya: A systematic review and meta-analysis. International Journal of Infectious Diseases 67, pages 107-113.
Crossref
Crossref
Anju Aggarwal & Neha Garg. (2017) Newer Vaccines against Mosquito-borne Diseases. The Indian Journal of Pediatrics 85:2, pages 117-123.
Crossref
Crossref
Scott C. Weaver, Caroline Charlier, Nikos Vasilakis & Marc Lecuit. (2018) Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases. Annual Review of Medicine 69:1, pages 395-408.
Crossref
Crossref
Anuj Sharma, Manish Bhomia, Tze-Jou Yeh, Jay Singh & Radha K. Maheshwari. (2018) Miltefosine inhibits Chikungunya virus replication in human primary dermal fibroblasts. F1000Research 7, pages 9.
Crossref
Crossref
J. Erin Staples & Ann M. Powers. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1126
1128.e2
.
Elizabeth D. Barnett, Phyllis E. Kozarsky & Robert Steffen. 2018. Plotkin's Vaccines. Plotkin's Vaccines
1383
1401.e6
.
. 2018. Zika Virus. Zika Virus
27
45
.
R Carrasco-HernandezRodrigo JácomeYolanda López VidalSamuel Ponce de León. (2017) Are RNA Viruses Candidate Agents for the Next Global Pandemic? A Review. ILAR Journal 58:3, pages 343-358.
Crossref
Crossref
Chris M. Cirimotich, Eric M. Vela, Jennifer Garver, Roy E. Barnewall, Brian D. Miller, Gabriel T. Meister & James V. Rogers. (2017) Chikungunya virus infection in Cynomolgus macaques following Intradermal and aerosol exposure. Virology Journal 14:1.
Crossref
Crossref
Grace C. Roberts, Carsten Zothner, Roland Remenyi, Andres Merits, Nicola J. Stonehouse & Mark Harris. (2017) Evaluation of a range of mammalian and mosquito cell lines for use in Chikungunya virus research. Scientific Reports 7:1.
Crossref
Crossref
Shih-Chao Lin, Mei-Chun Chen, Shiming Li, Chi-Chen Lin & Tony T Wang. (2016)
Antiviral Activity of Nobiletin against Chikungunya virus
in vitro
. Antiviral Therapy 22:8, pages 689-697.
Crossref
Crossref
Sixun Yang, Doran Fink, Andrea Hulse & R. Douglas Pratt. (2017) Regulatory considerations in development of vaccines to prevent disease caused by Chikungunya virus. Vaccine 35:37, pages 4851-4858.
Crossref
Crossref
Jolene Ramsey & Suchetana Mukhopadhyay. (2017) Disentangling the Frames, the State of Research on the Alphavirus 6K and TF Proteins. Viruses 9:8, pages 228.
Crossref
Crossref
Talya Shragai, Blanka Tesla, Courtney Murdock & Laura C. Harrington. (2017) Zika and chikungunya: mosquito-borne viruses in a changing world. Annals of the New York Academy of Sciences 1399:1, pages 61-77.
Crossref
Crossref
Sompong Vongpunsawad, Duangnapa Intharasongkroh, Thanunrat Thongmee & Yong Poovorawan. (2017) Seroprevalence of antibodies to dengue and chikungunya viruses in Thailand. PLOS ONE 12:6, pages e0180560.
Crossref
Crossref
Pierre Roques, Karl Ljungberg, Beate M. Kümmerer, Leslie Gosse, Nathalie Dereuddre-Bosquet, Nicolas Tchitchek, David Hallengärd, Juan García-Arriaza, Andreas Meinke, Mariano Esteban, Andres Merits, Roger Le Grand & Peter Liljeström. (2017) Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus. JCI Insight 2:6.
Crossref
Crossref
Annelies Wilder-Smith, Duane J Gubler, Scott C Weaver, Thomas P Monath, David L Heymann & Thomas W Scott. (2017) Epidemic arboviral diseases: priorities for research and public health. The Lancet Infectious Diseases 17:3, pages e101-e106.
Crossref
Crossref
M. T. Akinola, A. D. EL-Yuguda, D. N. Bukbuk & S. S. Baba. (2017) Prevalence of IgG and IgM antibodies to Chikungunya virus among outpatients with febrile illness attending University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria. African Journal of Microbiology Research 11:7, pages 306-311.
Crossref
Crossref
Teck-Hui TeoYi-Hao ChanWendy W. L. LeeFok-Moon LumSiti Naqiah AmrunZhisheng HerRavisankar RajarethinamAndres MeritsOlaf RötzschkeLaurent RéniaLisa F. P. Ng. (2017) Fingolimod treatment abrogates chikungunya virus–induced arthralgia. Science Translational Medicine 9:375.
Crossref
Crossref
Marc Z. Handler, Nancy S. Handler, Matthew P. Stephany, Glenn A. Handler & Robert A. Schwartz. (2017) Chikungunya fever: an emerging viral infection threatening North America and Europe. International Journal of Dermatology 56:2, pages e19-e25.
Crossref
Crossref
Christopher Weber, Eva Berberich, Christine von Rhein, Lisa Henß, Eberhard Hildt & Barbara S. Schnierle. (2017) Identification of Functional Determinants in the Chikungunya Virus E2 Protein. PLOS Neglected Tropical Diseases 11:1, pages e0005318.
Crossref
Crossref
Katharina B. Lauer, Ray Borrow & Thomas J. Blanchard. (2017) Multivalent and Multipathogen Viral Vector Vaccines. Clinical and Vaccine Immunology 24:1.
Crossref
Crossref
Xinzhi Liu & Peter StechlinskiXinzhi Liu & Peter Stechlinski. 2017. Infectious Disease Modeling. Infectious Disease Modeling
227
257
.
I. W. FongI. W. Fong. 2017. Emerging Zoonoses. Emerging Zoonoses
101
130
.
Mawlouth Diallo, Ibrahima Dia, Diawo Diallo, Cheikh Tidiane Diagne, Yamar Ba & Sergio Yactayo. (2016) Perspectives and Challenges in Entomological Risk Assessment and Vector Control of Chikungunya. Journal of Infectious Diseases 214:suppl 5, pages S459-S465.
Crossref
Crossref
Katrin Ramsauer & Frédéric Tangy. (2016) Chikungunya Virus Vaccines: Viral Vector–Based Approaches: Table 1.. Journal of Infectious Diseases 214:suppl 5, pages S500-S505.
Crossref
Crossref
Lisa Henß, Simon Beck, Tatjana Weidner, Nadine Biedenkopf, Katja Sliva, Christopher Weber, Stephan Becker & Barbara S. Schnierle. (2016) Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry. Virology Journal 13:1.
Crossref
Crossref
Giovanni Rezza. (2016)
Vaccines against chikungunya, Zika and other emerging
Aedes
mosquito-borne viruses: unblocking existing bottlenecks
. Future Virology 11:11, pages 723-730.
Crossref
Crossref
Tankeu Nzufo Francine, Biapa Nya Prosper Cabral, Pieme Constant Anatole, Moukette Moukette Bruno, Nanfack Pauline & Ngogang Yonkeu Jeanne. (2016) Larvicidal activities of hydro-ethanolic extracts of three Cameroonian medicinal plants against Aedes albopictus. Asian Pacific Journal of Tropical Biomedicine 6:11, pages 931-936.
Crossref
Crossref
Marc P. Girard. (2016) Arboviroses et fièvres hémorragiques : actualités épidémiologique et vaccinale. Bulletin de l'Académie Nationale de Médecine 200:8-9, pages 1617-1630.
Crossref
Crossref
Leora R. FeldsteinEsther M. EllisAli Rowhani-RahbarM. Elizabeth HalloranBrett R. Ellis. (2016) The First Reported Outbreak of Chikungunya in the U.S. Virgin Islands, 2014–2015. The American Journal of Tropical Medicine and Hygiene 95:4, pages 885-889.
Crossref
Crossref
John M. Hickey, Neha Sahni, Ronald T. TothIVIV, Ozan S. Kumru, Sangeeta B. Joshi, C. Russell Middaugh & David B. Volkin. (2016) Challenges and opportunities of using liquid chromatography and mass spectrometry methods to develop complex vaccine antigens as pharmaceutical dosage forms. Journal of Chromatography B 1032, pages 23-38.
Crossref
Crossref
Shanmugaraj Bala Murugan & Ramalingam Sathishkumar. (2016) Chikungunya infection: A potential re-emerging global threat. Asian Pacific Journal of Tropical Medicine 9:10, pages 933-937.
Crossref
Crossref
Karuppiah Muthumani, Peter Block, Seleeke Flingai, Nagarajan Muruganantham, Itta Krishna Chaaithanya, Colleen Tingey, Megan Wise, Emma L. Reuschel, Christopher Chung, Abirami Muthumani, Gopalsamy Sarangan, Padma Srikanth, Amir S. Khan, Paluru Vijayachari, Niranjan Y. Sardesai, J. Joseph Kim, Kenneth E. Ugen & David B. Weiner. (2016) Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus. Journal of Infectious Diseases 214:3, pages 369-378.
Crossref
Crossref
Shantalasha Onika Knowles. (2016) Viral Mosquito-Borne Illnesses in Pregnancy: A Look at Aedes. Obstetrics & Gynecology International Journal 5:1.
Crossref
Crossref
Shweta Saraswat, T. N. Athmaram, Manmohan Parida, Ankita Agarwal, Amrita Saha & Paban Kumar Dash. (2016) Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate. PLOS Neglected Tropical Diseases 10:7, pages e0004782.
Crossref
Crossref
Sarah S. Long. (2016) Diagnosis and management of undifferentiated fever in children. Journal of Infection 72, pages S68-S76.
Crossref
Crossref
Cheng-Lin Deng, Si-Qing Liu, Dong-Gen Zhou, Lin-Lin Xu, Xiao-Dan Li, Pan-Tao Zhang, Peng-Hui Li, Han-Qing Ye, Hong-Ping Wei, Zhi-Ming Yuan, Cheng-Feng Qin & Bo Zhang. (2016) Development of Neutralization Assay Using an eGFP Chikungunya Virus. Viruses 8:7, pages 181.
Crossref
Crossref
Clayton R. Morrison, Kenneth S. Plante & Mark T. Heise. 2016. Emerging Infections 10. Emerging Infections 10
143
161
.
Priya Mishra, Colleen Furey, Velmurugan Balaraman & Malcolm Fraser. (2016) Antiviral Hammerhead Ribozymes Are Effective for Developing Transgenic Suppression of Chikungunya Virus in Aedes aegypti Mosquitoes. Viruses 8:6, pages 163.
Crossref
Crossref
Vini VijayanSukesh Sukumaran. (2016) Chikungunya Virus Disease. JCR: Journal of Clinical Rheumatology 22:4, pages 203-211.
Crossref
Crossref
Claire Smalley, Jesse H. Erasmus, Charles B. Chesson & David W.C. Beasley. (2016) Status of research and development of vaccines for chikungunya. Vaccine 34:26, pages 2976-2981.
Crossref
Crossref
Sonia Pagliusi, Ching-Chia Ting, Sumana Khomvilai, Akira Homma, Li Meng, Mahendra Suhardono, Patrick Tippoo, Suresh Jadhav, Steven Gao, Ray Prasad, Rajinder K. Suri, Pan Hong Thai & Vitoon Vonghangool. (2016) Quality vaccines for all people. Vaccine 34:31, pages 3562-3567.
Crossref
Crossref
B. Siva Raghavendhar, Pratima Ray, Vinod H. Ratagiri, B.S. Sharma, Sushil K. Kabra & Rakesh Lodha. (2016) Evaluation of chikungunya virus infection in children from India during 2009-2010: A cross sectional observational study. Journal of Medical Virology 88:6, pages 923-930.
Crossref
Crossref
Clayton R. Morrison, Kenneth S. Plante & Mark T. Heise. (2016) Chikungunya Virus: Current Perspectives on a Reemerging Virus. Microbiology Spectrum 4:3.
Crossref
Crossref
Heidi McGuigan. (2016) Global Health and Emerging Infectious Diseases. Journal of Emergency Nursing 42:3, pages 272-275.
Crossref
Crossref
Daryl Staveness, Rana Abdelnabi, Katherine E. Near, Yu Nakagawa, Johan Neyts, Leen Delang, Pieter Leyssen & Paul A. Wender. (2016) Inhibition of Chikungunya Virus-Induced Cell Death by Salicylate-Derived Bryostatin Analogues Provides Additional Evidence for a PKC-Independent Pathway. Journal of Natural Products 79:4, pages 680-684.
Crossref
Crossref
Daryl Staveness, Rana Abdelnabi, Adam J. Schrier, Brian A. Loy, Vishal A. Verma, Brian A. DeChristopher, Katherine E. Near, Johan Neyts, Leen Delang, Pieter Leyssen & Paul A. Wender. (2016) Simplified Bryostatin Analogues Protect Cells from Chikungunya Virus-Induced Cell Death. Journal of Natural Products 79:4, pages 675-679.
Crossref
Crossref
David WC Beasley & John G Aaskov. (2016) Challenges for the utilization of vaccines against arthritogenic alphaviruses. Future Virology 11:4, pages 235-238.
Crossref
Crossref
Sheli R. Radoshitzky, Gianluca Pegoraro, Xi?ol? Ch?Li?n D?ng, Chih-Yuan Chiang, Lucas Jozwick, Jeremiah C. Clester, Christopher L. Cooper, Duane Courier, David P. Langan, Knashka Underwood, Kathleen A. Kuehl, Mei G. Sun, Y?ngy?n Ca?Shu?q?ng Y?Robin Burk, Rouzbeh Zamani, Krishna Kota, Jens H. Kuhn & Sina Bavari. (2016) siRNA Screen Identifies Trafficking Host Factors that Modulate Alphavirus Infection. PLOS Pathogens 12:3, pages e1005466.
Crossref
Crossref
Rachmat Hidajat, Brian Nickols, Naomi Forrester, Irina Tretyakova, Scott Weaver & Peter Pushko. (2016) Next generation sequencing of DNA-launched Chikungunya vaccine virus. Virology 490, pages 83-90.
Crossref
Crossref
Rueshandra Roosenhoff, Fatih Anfasa & Byron Martina. (2016) The pathogenesis of chronic chikungunya: evolving concepts. Future Virology 11:1, pages 61-77.
Crossref
Crossref
Christian Therrien, Guillaume Jourdan, Kimberly Holloway, C?cile Tremblay & Michael A. Drebot. (2016) First Imported Case of Chikungunya Virus Infection in a Travelling Canadian Returning from the Caribbean. Canadian Journal of Infectious Diseases and Medical Microbiology 2016, pages 1-5.
Crossref
Crossref
Jaime R. Torres, Leopoldo G. Córdova, Víctor Saravia, Joanne Arvelaez & Julio S. Castro. (2016) Nasal Skin Necrosis: An Unexpected New Finding in Severe Chikungunya Fever. Clinical Infectious Diseases 62:1, pages 78-81.
Crossref
Crossref
Christine von Rhein, Tatjana Weidner, Lisa Henß, Judith Martin, Christopher Weber, Katja Sliva & Barbara S. Schnierle. (2016) Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro. Antiviral Research 125, pages 51-57.
Crossref
Crossref
Hong Zhang, Paul Georgescu & Adamu Shitu Hassan. (2016) Mathematical insights and integrated strategies for the control of Aedes aegypti mosquito. Applied Mathematics and Computation 273, pages 1059-1089.
Crossref
Crossref
Adam DeZure & Barney S. Graham. 2016. The Vaccine Book. The Vaccine Book
543
560
.
Karl Ljungberg, Beate M. Kümmerer, Pierre Roques, Mariano Esteban, Andres Merits & Peter Liljeström. 2016. Chikungunya Virus. Chikungunya Virus
45
62
.
Christine Loan Ping Eng, Tin Wee Tan & Joo Chuan Tong. 2016. Chikungunya Virus. Chikungunya Virus
201
207
.
Jelke J. Fros, Corinne Geertsema, Karima Zouache, Jim Baggen, Natalia Domeradzka, Daniël M. van Leeuwen, Jacky Flipse, Just M. Vlak, Anna-Bella Failloux & Gorben P. Pijlman. (2015) Mosquito Rasputin interacts with chikungunya virus nsP3 and determines the infection rate in Aedes albopictus. Parasites & Vectors 8:1.
Crossref
Crossref
G. Añez, Z. Jiang, D. A. R. Heisey, S. Kerby & M. Rios. (2015) Collaborative study for the characterization of a chikungunya virus RNA reference reagent for use in nucleic acid testing. Vox Sanguinis 109:4, pages 312-318.
Crossref
Crossref
Margaret Kielian & Erica Ollmann Saphire. (2015) Potent Antibody Protection against an Emerging Alphavirus Threat. Cell 163:5, pages 1053-1054.
Crossref
Crossref
Dhiraj Acharya, Amber M. Paul, John F. Anderson, Faqing Huang & Fengwei Bai. (2015) Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity. PLOS Neglected Tropical Diseases 9:10, pages e0004139.
Crossref
Crossref
Kenneth S Plante, Shannan L. Rossi, Nicholas A. Bergren, Robert L. Seymour & Scott C. Weaver. (2015) Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate. PLOS Neglected Tropical Diseases 9:9, pages e0004007.
Crossref
Crossref
Benjamin M. Althouse & Kathryn A. Hanley. (2015) The tortoise or the hare? Impacts of within-host dynamics on transmission success of arthropod-borne viruses. Philosophical Transactions of the Royal Society B: Biological Sciences 370:1675, pages 20140299.
Crossref
Crossref
Mareike van Duijl-Richter, Tabitha Hoornweg, Izabela Rodenhuis-Zybert & Jolanda Smit. (2015) Early Events in Chikungunya Virus Infection—From Virus CellBinding to Membrane Fusion. Viruses 7:7, pages 3647-3674.
Crossref
Crossref
Jorge A. Salazar-González, Carlos Angulo & Sergio Rosales-Mendoza. (2015) Chikungunya virus vaccines: Current strategies and prospects for developing plant-made vaccines. Vaccine 33:31, pages 3650-3658.
Crossref
Crossref
K.A. Galán-Huerta, A.M. Rivas-Estilla, I. Fernández-Salas, J.A. Farfan-Ale & J. Ramos-Jiménez. (2015) Chikungunya virus: A general overview. Medicina Universitaria 17:68, pages 175-183.
Crossref
Crossref
Xinzhi Liu & Peter Stechlinski. (2015) Application of control strategies to a seasonal model of chikungunya disease. Applied Mathematical Modelling 39:12, pages 3194-3220.
Crossref
Crossref
In-Kyu Yoon, Maria Theresa Alera, Catherine B. Lago, Ilya A. Tac-An, Daisy Villa, Stefan Fernandez, Butsaya Thaisomboonsuk, Chonticha Klungthong, Jens W. Levy, John Mark Velasco, Vito G. Roque, Henrik Salje, Louis R. Macareo, Laura L. Hermann, Ananda Nisalak & Anon Srikiatkhachorn. (2015) High Rate of Subclinical Chikungunya Virus Infection and Association of Neutralizing Antibody with Protection in a Prospective Cohort in The Philippines. PLOS Neglected Tropical Diseases 9:5, pages e0003764.
Crossref
Crossref
Md. Anayet Hasan, Md. Arif Khan, Amit Datta, Md. Habibul Hasan Mazumder & Mohammad Uzzal Hossain. (2015) A comprehensive immunoinformatics and target site study revealed the corner-stone toward Chikungunya virus treatment. Molecular Immunology 65:1, pages 189-204.
Crossref
Crossref
Katrin Ramsauer, Michael Schwameis, Christa Firbas, Matthias M?llner, Robert J Putnak, Stephen J Thomas, Philippe Despr?s, Erich Tauber, Bernd Jilma & Frederic Tangy. (2015) Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. The Lancet Infectious Diseases 15:5, pages 519-527.
Crossref
Crossref
M Zuluaga-Gómez & D Vanegas-Isaza. (2015) El virus Chikungunya en Colombia: aspectos clínicos y epidemiológicos y revisión de la literatura. IATREIA 29:1.
Crossref
Crossref
Tero AholaTherese CoudercLisa F.P. NgDavid HallengärdAnn PowersMarc LecuitMariano EstebanAndres MeritsPierre RoquesPeter Liljeström. (2015) Therapeutics and Vaccines Against Chikungunya Virus. Vector-Borne and Zoonotic Diseases 15:4, pages 250-257.
Crossref
Crossref
Scott C. Weaver & Marc Lecuit. (2015) Chikungunya Virus and the Global Spread of a Mosquito-Borne Disease. New England Journal of Medicine 372:13, pages 1231-1239.
Crossref
Crossref
Phitchayapak Wintachai, Frédéric Thuaud, Christine Basmadjian, Sittiruk Roytrakul, Sukathida Ubol, Laurent Désaubry & Duncan R. Smith. (2015) Assessment of flavaglines as potential chikungunya virus entry inhibitors. Microbiology and Immunology 59:3, pages 129-141.
Crossref
Crossref
Virginie Rougeron, I-Ching Sam, M?lanie Caron, Dieudonn? Nkoghe, Eric Leroy & Pierre Roques. (2015) Chikungunya, a paradigm of neglected tropical disease that emerged to be a new health global risk. Journal of Clinical Virology 64, pages 144-152.
Crossref
Crossref
Licia Bordi, Claudia Caglioti, Eleonora Lalle, Concetta Castilletti & Maria Rosaria Capobianchi. (2015) Chikungunya and Its Interaction With the Host Cell. Current Tropical Medicine Reports 2:1, pages 22-29.
Crossref
Crossref
Federico Gobbi, Dora Buonfrate, Andrea Angheben, Monica Degani & Zeno Bisoffi. (2015) Emergence and Surveillance of Chikungunya. Current Tropical Medicine Reports 2:1, pages 4-12.
Crossref
Crossref
Christopher Weber, Katja Sliva, Christine von Rhein, Beate M. Kümmerer & Barbara S. Schnierle. (2015) The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection. Antiviral Research 113, pages 1-3.
Crossref
Crossref
Rima Khabbaz, Beth P. Bell, Anne Schuchat, Stephen M. Ostroff, Robin Moseley, Alexandra Levitt & James M. Hughes. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
158
177.e6
.
Rachel H. Fong, Soma S. R. Banik, Kimberly Mattia, Trevor Barnes, David Tucker, Nathan Liss, Kai Lu, Suganya Selvarajah, Surabhi Srinivasan, Manu Mabila, Adam Miller, Marcus O. Muench, Alain Michault, Joseph B. Rucker, Cheryl Paes, Graham Simmons, Kristen M. Kahle & Benjamin J. Doranz. (2014) Exposure of Epitope Residues on the Outer Face of the Chikungunya Virus Envelope Trimer Determines Antibody Neutralizing Efficacy. Journal of Virology 88:24, pages 14364-14379.
Crossref
Crossref
Lee-Jah Chang, Kimberly A Dowd, Floreliz H Mendoza, Jamie G Saunders, Sandra Sitar, Sarah H Plummer, Galina Yamshchikov, Uzma N Sarwar, Zonghui Hu, Mary E Enama, Robert T Bailer, Richard A Koup, Richard M Schwartz, Wataru Akahata, Gary J Nabel, John R Mascola, Theodore C Pierson, Barney S Graham & Julie E Ledgerwood. (2014) Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. The Lancet 384:9959, pages 2046-2052.
Crossref
Crossref
Lark Coffey, Anna-Bella Failloux & Scott Weaver. (2014) Chikungunya Virus–Vector Interactions. Viruses 6:11, pages 4628-4663.
Crossref
Crossref
David Hallengärd, Fok-Moon Lum, Beate M. Kümmerer, Aleksei Lulla, Valeria Lulla, Juan García-Arriaza, John K. Fazakerley, Pierre Roques, Roger Le Grand, Andres Merits, Lisa F. P. Ng, Mariano Esteban & Peter Liljeström. (2014) Prime-Boost Immunization Strategies against Chikungunya Virus. Journal of Virology 88:22, pages 13333-13343.
Crossref
Crossref
Thomas E. Morrison. (2014) Reemergence of Chikungunya Virus. Journal of Virology 88:20, pages 11644-11647.
Crossref
Crossref
David M. Morens & Anthony S. Fauci. (2014) Chikungunya at the Door — Déjà Vu All Over Again?. New England Journal of Medicine 371:10, pages 885-887.
Crossref
Crossref
Promsin Masrinoul, Orapim Puiprom, Atsushi Tanaka, Miwa Kuwahara, Panjaporn Chaichana, Kazuyoshi Ikuta, Pongrama Ramasoota & Tamaki Okabayashi. (2014) Monoclonal antibody targeting chikungunya virus envelope 1 protein inhibits virus release. Virology 464-465, pages 111-117.
Crossref
Crossref
William J. Weise, Meghan E. Hermance, Naomi Forrester, A. Paige Adams, Rose Langsjoen, Rodion Gorchakov, Eryu Wang, Maria D. H. Alcorn, Konstantin Tsetsarkin & Scott C. Weaver. (2014) A Novel Live-Attenuated Vaccine Candidate for Mayaro Fever. PLoS Neglected Tropical Diseases 8:8, pages e2969.
Crossref
Crossref
Nasamon Wanlapakorn, Thanunrat Thongmee, Piyada Linsuwanon, Paiboon Chattakul, Sompong Vongpunsawad, Sunchai Payungporn & Yong Poovorawan. (2014) Chikungunya Outbreak in Bueng Kan Province, Thailand, 2013. Emerging Infectious Diseases 20:8, pages 1404-1406.
Crossref
Crossref
Pankaj Pal, Julie M. Fox, David W. Hawman, Yan-Jang S. Huang, Ilhem Messaoudi, Craig Kreklywich, Michael Denton, Alfred W. Legasse, Patricia P. Smith, Syd Johnson, Michael K. Axthelm, Dana L. Vanlandingham, Daniel N. Streblow, Stephen Higgs, Thomas E. Morrison & Michael S. Diamond. (2014) Chikungunya Viruses That Escape Monoclonal Antibody Therapy Are Clinically Attenuated, Stable, and Not Purified in Mosquitoes. Journal of Virology 88:15, pages 8213-8226.
Crossref
Crossref
James Weger-Lucarelli, Haiyan Chu, Matthew T. Aliota, Charalambos D. Partidos & Jorge E. Osorio. (2014) A Novel MVA Vectored Chikungunya Virus Vaccine Elicits Protective Immunity in Mice. PLoS Neglected Tropical Diseases 8:7, pages e2970.
Crossref
Crossref
Mathilda Sjöberg. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Scott C. Weaver. (2014) Arrival of Chikungunya Virus in the New World: Prospects for Spread and Impact on Public Health. PLoS Neglected Tropical Diseases 8:6, pages e2921.
Crossref
Crossref
Irina Tretyakova, Jason Hearn, Eryu Wang, Scott Weaver & Peter Pushko. (2014) DNA Vaccine Initiates Replication of Live Attenuated Chikungunya Virus In Vitro and Elicits Protective Immune Response in Mice. The Journal of Infectious Diseases 209:12, pages 1882-1890.
Crossref
Crossref
C. J. Roy, A. P. Adams, E. Wang, K. Plante, R. Gorchakov, R. L. Seymour, H. Vinet-Oliphant & S. C. Weaver. (2014) Chikungunya Vaccine Candidate Is Highly Attenuated and Protects Nonhuman Primates Against Telemetrically Monitored Disease Following a Single Dose. Journal of Infectious Diseases 209:12, pages 1891-1899.
Crossref
Crossref
James M. Wagner, J. David Pajerowski, Christopher L. Daniels, Patrick M. McHugh, Jessica A. Flynn, John W. Balliet, Danilo R. Casimiro & Shyamsundar Subramanian. (2014) Enhanced Production of Chikungunya Virus-Like Particles Using a High-pH Adapted Spodoptera frugiperda Insect Cell Line. PLoS ONE 9:4, pages e94401.
Crossref
Crossref
Juan García-Arriaza, Victoria Cepeda, David Hallengärd, Carlos Óscar S. Sorzano, Beate Mareike Kümmerer, Peter Liljeström & Mariano Esteban. (2014) A Novel Poxvirus-Based Vaccine, MVA-CHIKV, Is Highly Immunogenic and Protects Mice against Chikungunya Infection. Journal of Virology 88:6, pages 3527-3547.
Crossref
Crossref
Sarunyou Chusri, Pisud Siripaitoon, Kachornsak Silpapojakul, Thanaporn Hortiwakul, Boonsri Charernmak, Piyawan Chinnawirotpisan, Ananda Nisalak, Butsaya Thaisomboonsuk, Chonticha Klungthong, Robert V. Gibbons & Richard G. Jarman. (2014) Kinetics of Chikungunya Infections during an Outbreak in Southern Thailand, 2008–2009. The American Journal of Tropical Medicine and Hygiene 90:3, pages 410-417.
Crossref
Crossref
Christina L. Gardner, Jozef Hritz, Chengqun Sun, Dana L. Vanlandingham, Timothy Y. Song, Elodie Ghedin, Stephen Higgs, William B. Klimstra & Kate D. Ryman. (2014) Deliberate Attenuation of Chikungunya Virus by Adaptation to Heparan Sulfate-Dependent Infectivity: A Model for Rational Arboviral Vaccine Design. PLoS Neglected Tropical Diseases 8:2, pages e2719.
Crossref
Crossref
Chong Long Chua, Yoke Fun Chan & I-Ching Sam. (2014) Characterisation of mouse monoclonal antibodies targeting linear epitopes on Chikungunya virus E2 glycoprotein. Journal of Virological Methods 195, pages 126-133.
Crossref
Crossref
Peter Pushko, Peter P. Bredenbeek & Igor S. Lukashevich. 2014. Novel Technologies for Vaccine Development. Novel Technologies for Vaccine Development
153
177
.
Scott C. Weaver & Ann M. Powers. 2014. Viral Infections of Humans. Viral Infections of Humans
123
145
.
Scott C. Weaver. (2013) Urbanization and geographic expansion of zoonotic arboviral diseases: mechanisms and potential strategies for prevention. Trends in Microbiology 21:8, pages 360-363.
Crossref
Crossref
Amanda Piper, Mariana Ribeiro, Katherine M. Smith, Caitlin M. Briggs, Emerson Huitt, Kavita Nanda, Carla J. Spears, Michelle Quiles, John Cullen, Malcolm E. Thomas, Dennis T. Brown & Raquel Hernandez. (2013) Chikungunya Virus Host Range E2 Transmembrane Deletion Mutants Induce Protective Immunity against Challenge in C57BL/6J Mice. Journal of Virology 87:12, pages 6748-6757.
Crossref
Crossref
Lark L Coffey, Naomi Forrester, Konstantin Tsetsarkin, Nikos Vasilakis & Scott C Weaver. (2013) Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease. Future Microbiology 8:2, pages 155-176.
Crossref
Crossref